Celldex Therapeutics, Inc
$38.51
-$0.67 (-1.71%)
$37.74Day Range$39.19
Key Statistics
Market Cap
$3.02B
Shares Outstanding
78.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 15, 1986
Round Lot
100
Locale
US
Trading Data
Day Open
$39.00
Day High
$39.19
Day Low
$37.74
Volume
686.4K
VWAP
$38.27
Prev Close
$39.18
Transactions
--
Acc. Volume
--
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESSIC 2835198 employees53 FRONTAGE ROAD, HAMPTON, NJ, 08827908-200-7500IPO May 15, 1986US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000744218
- Composite FIGI
- BBG000FW8LZ9
- Share Class FIGI
- BBG001S7QN20
- Ticker Root
- CLDX
- SIC Code
- 2835
About Celldex Therapeutics, Inc (CLDX) Stock
Celldex Therapeutics, Inc (CLDX) closed the 2026-09-15 session at $38.51, down 1.71% versus the previous close (-0.67). The stock opened at $39.00 and traded between $37.74 and $39.19 during that session. Session trading volume was 686K shares. The volume-weighted average price (VWAP) is $38.27.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Celldex Therapeutics, Inc has a market capitalization of $3.02 billion. The company operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry classification. CLDX is listed on the XNAS exchange. The company employs approximately 198 people. Celldex Therapeutics, Inc is headquartered in HAMPTON, NJ. The recorded listing date is 1986-05-15.
On this page you can find market CLDX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.